All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: HBV-HIV Coinfection-23029487

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	23029487	A1762T	BCP		HBV-HIV Coinfection	G S C L	View
2	23029487	C1858T	PreC	C	HBV-HIV Coinfection	G S C L	View
3	23029487	G1764A	BCP		HBV-HIV Coinfection	G S C L	View
4	23029487	G1862T	PreC	C	HBV-HIV Coinfection	G S C L	View
5	23029487	G1896A	PreC	C	HBV-HIV Coinfection	G S C L	View
6	23029487	L180M	RT	P	HBV-HIV Coinfection	G S C L	View
7	23029487	M204V	RT	P	HBV-HIV Coinfection	G S C L	View
8	23029487	V173L	RT	P	HBV-HIV Coinfection	G S C L	View
9	23029487	V214A	RT	P	HBV-HIV Coinfection	G S C L	View
10	23029487	I48V	PreS1	S	HBV-HIV Coinfection	G S C L	View
11	23029487	Q10R	PreS2	S	HBV-HIV Coinfection	G S C L	View
12	23029487	Q129H	S	S	HBV-HIV Coinfection	G S C L	View
13	23029487	Q129R	S	S	HBV-HIV Coinfection	G S C L	View
14	23029487	A53V	PreS2	S	HBV-HIV Coinfection	G S C L	View
15	23029487	F25L	PreS1	S	HBV-HIV Coinfection	G S C L	View
16	23029487	I48T	PreS1	S	HBV-HIV Coinfection	G S C L	View
17	23029487	S174N	S	S	HBV-HIV Coinfection	G S C L	View
18	23029487	V168A	S	S	HBV-HIV Coinfection	G S C L	View
19	23029487	V88A	PreS1	S	HBV-HIV Coinfection	G S C L	View
20	23029487	V88L	PreS1	S	HBV-HIV Coinfection	G S C L	View
21	23029487	Q164A	S	S	HBV-HIV Coinfection	G S C L	View
22	23029487	Q164D	S	S	HBV-HIV Coinfection	G S C L	View
23	23029487	Q164G	S	S	HBV-HIV Coinfection	G S C L	View
24	23029487	Q164V	S	S	HBV-HIV Coinfection	G S C L	View
25	23029487	R48K	PreS2	S	HBV-HIV Coinfection	G S C L	View
26	23029487	R48T	PreS2	S	HBV-HIV Coinfection	G S C L	View
27	23029487	T1884C	BCP;PreC	C	HBV-HIV Coinfection	G S C L	View
28	23029487	E1D	RT	P	HBV-HIV Coinfection	G S C L	View
29	23029487	L28P	P	P	HBV-HIV Coinfection	G S C L	View
30	23029487	P132Q	P	P	HBV-HIV Coinfection	G S C L	View
31	23029487	Q23K	P	P	HBV-HIV Coinfection	G S C L	View
32	23029487	S91I	P	P	HBV-HIV Coinfection	G S C L	View
33	23029487	T1753C	BCP		HBV-HIV Coinfection	G S C L	View
34	23029487	H122N	RT	P	HBV-HIV Coinfection	G S C L	View
35	23029487	Q125E	RT	P	HBV-HIV Coinfection	G S C L	View
36	23029487	S105T	RT	P	HBV-HIV Coinfection	G S C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.